z-logo
open-access-imgOpen Access
The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation
Author(s) -
Esteban Porrini,
Patricia Delgado,
Alejandra Alvarez,
María Luisa Cagigal,
Luis Figuero-Pérez,
José Manuel GonzálezPosada,
L Hortal,
Roberto Gallego,
J. García,
Milagros Arteaga Checa,
Adelaida Morales,
Eduardo Salido,
Domingo Hernández,
Armando Torres
Publication year - 2007
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfm762
Subject(s) - medicine , calcineurin , diabetes mellitus , transplantation , type 2 diabetes , triglyceride , urology , renal transplant , endocrinology , cholesterol
Insulin resistance precedes overt diabetes in the general population and hypertriglyceridemia is a reliable marker of the disorder. Thus, patients in the waiting list with hypertriglyceridemia may be at risk for new-onset diabetes after transplantation (NODAT). Objectives. We investigate whether pre-transplant triglyceride (TG) levels are a risk factor for NODAT and whether they exert a combined effect with the type of calcineurin inhibitor (CNI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom